Protein poly(ADP-ribosyl)ation (PARylation) has a role in diverse cellular processes such as DNA repair, transcription, Wnt signalling, and cell death 1-6 . Recent studies have shown that PARylation can serve as a signal for the polyubiquitination and degradation of several crucial regulatory proteins, including . The RING-type E3 ubiquitin ligase RNF146 (also known as Iduna) is responsible for PARylation-dependent ubiquitination (PARdU) 10-12 .
Protein poly(ADP-ribosyl)ation (PARylation) has a role in diverse cellular processes such as DNA repair, transcription, Wnt signalling, and cell death 1-6 . Recent studies have shown that PARylation can serve as a signal for the polyubiquitination and degradation of several crucial regulatory proteins, including Axin and 3BP2 (refs 7-9) . The RING-type E3 ubiquitin ligase RNF146 (also known as Iduna) is responsible for PARylation-dependent ubiquitination (PARdU) [10] [11] [12] .
Here we provide a structural basis for RNF146-catalysed PARdU and how PARdU specificity is achieved. First, we show that iso-ADP-ribose (iso-ADPr), the smallest internal poly(ADP-ribose) (PAR) structural unit, binds between the WWE and RING domains of RNF146 and functions as an allosteric signal that switches the RING domain from a catalytically inactive state to an active one. In the absence of PAR, the RING domain is unable to bind and activate a ubiquitin-conjugating enzyme (E2) efficiently. Binding of PAR or iso-ADPr induces a major conformational change that creates a functional RING structure. Thus, RNF146 represents a new mechanistic class of RING E3 ligases, the activities of which are regulated by non-covalent ligand binding, and that may provide a template for designing inducible proteindegradation systems. Second, we find that RNF146 directly interacts with the PAR polymerase tankyrase (TNKS). Disruption of the RNF146-TNKS interaction inhibits turnover of the substrate Axin in cells. Thus, both substrate PARylation and PARdU are catalysed by enzymes within the same protein complex, and PARdU substrate specificity may be primarily determined by the substrate-TNKS interaction. We propose that the maintenance of unliganded RNF146 in an inactive state may serve to maintain the stability of the RNF146-TNKS complex, which in turn regulates the homeostasis of PARdU activity in the cell.
Two domains can be identified within the 358-residue sequence of RNF146: an amino-terminal RING domain, followed by a WWE domain that binds iso-ADPr 13 (Fig. 1a and Extended Data Fig. 1 ). RING E3 ligases activate a ubiquitin-conjugating enzyme (E2) to transfer ubiquitin directly from the E2 active site to a lysine residue of a substrate. The intrinsic ability of RING E3s to stimulate ubiquitin (Ub) transfer can be assayed by following Ub transfer from E2,Ub (activated complex with a thioester linkage) to free amino acid lysine 14 . Unexpectedly, neither the purified RNF146(RING) domain nor full-length RNF146 significantly enhance the rate of Ub transfer from UbcH5,Ub to lysine ( Fig. 1b and Extended Data Fig. 2a ). However, addition of the WWE ligands iso-ADPr or PAR to the full-length RNF146 or a fragment containing the RING and WWE domains (termed RNF146(RING-WWE)), but not a RING-only construct, results in robust activation ( Fig. 1 and Extended Data Fig. 2) , consistent with reports that RNF146 is a PARylation-dependent E3 (refs [10] [11] [12] . Isothermal titration calorimetry (ITC) analysis shows that iso-ADPr binds to RNF146(RING-WWE) ten times tighter than to the WWE domain alone (dissociation constant (K d ) values of 39 nM and 372 nM, respectively; Extended Data Fig. 3a, b ), suggesting that the presence of the RING domain contributes to ligand binding. Furthermore, RNF146(RING-WWE) is sensitive to subtilisin digestion in the absence of iso-ADPr, but is more resistant to proteolysis in the presence of iso-ADPr (Extended Data Fig. 3c ), and NMR experiments indicate structural changes within the RING domain of the RING-WWE fragment after iso-ADPr binding (Extended Data Fig. 4 ). Altogether, the data indicate that both the RING and WWE domains are involved in iso-ADPr binding and that ligand binding affects the conformation and/or stability of the RING domain, leading to increased E3 ligase activity.
The structural basis of RNF146 activation by iso-ADPr or PAR is evident in a 1.9 Å crystal structure of a RNF146(RING-WWE)-UbcH5aiso-ADPr complex ( Fig. 2 and Extended Data Table 1 ). The RING domain structure is largely similar to other structurally characterized RINGs (see below), and the RNF146(WWE) domain structure is almost identical to an existing crystal structure 13 (Extended Data Fig. 5a ). The most notable feature is the location of iso-ADPr, which contacts both the RING and WWE domains ( Fig. 2b and Extended Data Fig. 5b, c) . Contacts between the WWE domain and iso-ADPr are similar to those previously described 13 .
*These authors contributed equally to this work. Lys 61 from the RING domain is within hydrogen-bond distance to hydroxyl groups on both ribose moieties of iso-ADPr and to a water molecule that can mediate a hydrogen bond with the adenine ring. In addition, RING residue Trp 65 forms a hydrogen bond with a main-chain carbonyl in the WWE domain and has van der Waals contacts with the ligand. Although iso-ADPr is buried in a valley between the RING and WWE domains, the phosphate groups on either end of iso-ADPr are exposed. Thus, the observed ligand orientation is consistent with the notion that RNF146 binds an internal unit of a PAR polymer.
In the crystal, the E2 enzyme UbcH5a binds to the RING domain at the canonical E2-E3 interface, away from the iso-ADPr-binding site ( Fig. 2a ). Similar to other RING E3-E2 complex structures [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , two Zn 21 -binding loops and the central helix of the RING bind E2 loops 4 and 7. A slight difference in the orientation of the RING and E2 relative to other E2-E3 complex structures is probably due to crystal packing (Extended Data Fig. 6 ), as the E2-E3 interactions observed in solution by NMR are similar to other well-characterized systems (see below).
Insight into the conformational changes that accompany iso-ADPr binding is provided by comparison to an NMR structure of the unliganded RNF146(RING) domain (Protein Data Bank (PDB) accession 2D8T; RIKEN Structural Genomics/Proteomics Initiative). In the unliganded RING domain the central helix is one turn shorter, with residues 62-66 instead forming a loop that protrudes into the E2-E3 binding interface ( Fig. 3a and Extended Data Fig. 7a ). Trp 65 makes hydrophobic interactions with Ile 36, Leu 66, and Ala 71 and is in a position to block E2 binding. Residues 62-66 adopt the helical structure associated with active RING domains in the iso-ADPr-bound structure. Thus, the RNF146(RING) domain can adopt two different conformations, and binding of iso-ADPr stabilizes an active structure with a functional E2binding surface.
The proposed model is supported by NMR binding experiments. Addition of unliganded RNF146(RING-WWE) resulted in very minor perturbations to the NMR spectrum of 15 N-UbcH5c while extensive perturbations occurred when iso-ADPr was also present ( Fig. 3b and Extended Data Fig. 7b ). Furthermore, the observed perturbations are highly similar to those observed with other RING-type E3s binding to UbcH5 and to UbcH5,Ub 21, 25 (Fig. 3b and Extended Data Fig. 7c, d ).
Mutational analysis was performed to understand the function of key residues in the iso-ADPr-induced conformational switch. Mutation of RING Lys 61, which makes several contacts with iso-ADPr, to Ala or Asp increased the K d for iso-ADPr to values comparable to that of the WWE domain alone (K d values of 214 nM (RING-WWE(Lys61Ala)) or 457 nM (RING-WWE(Lys61Asp)) versus 372 nM (WWE); Extended Data Fig. 3a, b ). Although the Lys61Asp mutant can still bind ligand, it is not activated by iso-ADPr ( Fig. 3c and Extended Data Fig. 8a ). Thus, Lys 61 serves to couple ligand binding to the activation of the RING domain. RING Gly 62 may serve to maintain the inactive RING conformation by disrupting the central helix (Extended Data Fig. 8b ). Mutation of Gly 62 to Ala in the context of both the RNF146(RING) and RNF146(RING-WWE) constructs was performed. In the absence of ligand, the mutants promote E2,Ub lysine reactivity ( Fig. 3c and Extended 
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Data Fig. 8c ). RNF146(RING)(Gly62Ala) also shows increased E2 binding in NMR experiments (Extended Data Fig. 8d ). Thus, Gly 62 may have a key role in the conformational transition of the central helix.
Likewise, a Trp65Ala mutation in RNF146(RING-WWE) to disrupt Trp 65 interactions in the inactive state also increased basal E3 activity (Fig. 3c ). The double mutant Gly62Ala/Trp65Ala of RNF146(RING-WWE) exhibits still greater activity than either of the single mutants (Fig. 3c) . The mutational results are consistent with our model in which extension of the RING central helix and repositioning of Trp 65 from the E2-E3-binding site to the RING-iso-ADPr interface constitute the allosteric switch triggered by ligand binding. Almost all known proteins regulated by PARdU, including Axin and 3BP2, are PARylated by TNKS 8,10-12 . We sought to understand the specificity of RNF146 by testing for a direct interaction between RNF146 and TNKS. Both glutathione S-transferase (GST) pull-down assays and co-migration on size-exclusion chromatography (SEC) showed that full-length RNF146 forms a stable complex with the five ankyrin repeat clusters (ARCs) of TNKS (TNKS(5ARC), residues 173-961) ( Fig. 4a and Extended Data Fig. 9a ). Co-immunoprecipitation and pull-down assays using full-length TNKS further support the direct RNF146-TNKS interaction in cells (Extended Data Fig. 9b, c) .
The ARCs of TNKS recognize a consensus motif of RXXGDG 6, 9 , although our recent work suggested that deviations may be tolerated in some circumstances 26 . As RNF146 contains no consensus motifs, we used molecular modelling to identify potential TNKS-binding sequences. Five potential motifs reside in the carboxy-terminal region of RNF146 (motif I to V; Fig. 1a and Extended Data Fig. 1 ); motif I (residues 193-199) is the most conserved. A C-terminal truncation (RNF146(1-183)) could not bind to the ARCs of TNKS, but a construct that includes motif I (RNF146 (1-205)) bound TNKS(5ARC) detectably (Fig. 4a ). In the context of full-length RNF146, mutations in either motif I (Gly199Val) or motif IV (Gly337Val/Gly338Val) reduced but did not abrogate the observed binding to TNKS(5ARC), with the motif I mutation having a stronger effect (Fig. 4a ).
Knockdown of RNF146 in cells by short interfering RNA (siRNA) leads to increased steady-state levels of Axin, and this effect is reversed by RNF146 expression 7, 11 (Fig. 4b) . By contrast, expression of the allostericswitch mutant RNF146(Lys61Asp) resulted in similar Axin levels to the no-RNF146 control. Disruption of the RNF146-TNKS complex via expression of the triple mutant RNF146(Gly199Val/Gly337Val/ Gly338Val) also led to increased Axin levels (Fig. 4b) . Thus, coupling of PAR binding to the stimulation of E3 activity, and the ability to form an RNF146-TNKS complex are both crucial to cellular PARdU regulation and turnover of Axin.
In summary, we propose that RNF146 and TNKS exist as a complex in which the RING domain is predominantly in an inactive state ( Fig. 4c ). TNKS is responsible for substrate selection and PARylation. Subsequent ubiquitination of the PARylated substrate requires that an internal PAR moiety binds to RNF146 to trigger the allosteric switch to the RING E3active state. PARylated substrate is probably held in the RNF146-TNKS complex via its interaction with TNKS, as the RNF146-TNKS interaction is required for ubiquitination of substrate in cells. Thus, our studies have revealed specific insights into the regulatory and substrate-recruitment mechanism of PARdU and have defined the molecular mechanism by which the RNF146(RING) domain is allosterically switched by noncovalent small molecule binding. These insights may aid in the design of RNF146 inhibitors that may be useful for cancer treatment, as RNF146 overexpression is associated with lung cancer 27 . Furthermore, data presented here may provide insight into studies of PAR-dependent cell death (PARthanatos), in which RNF146 was identified to be important in protecting cells from PARthanatos 12,28 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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METHODS
Plasmids, protein expression and purification. Human RNF146 was subcloned into a pET-28a vector with an N-terminal His 6 and T7 tags and a tobacco etch virus (TEV) cleavage site, and a pGEX-6P-2 vector with an N-terminal GST and Cterminal His 6 tag. Mouse RNF146(RING-WWE) (residues 30-183), which has an identical protein sequence to human RNF146 in this region, was subcloned into a pGEX-4T-1 vector with an N-terminal GST tag and TEV cleavage site. GST-tagged human tankyrase 1 fragment containing all five ankyrin repeat clusters (TNKS(5ARC); residues 173-961) was expressed from a pGEX-4T-1 vector with an N-terminal GST tag and TEV cleavage site. Full-length mouse TNKS was cloned into a pET-15b plasmid. Mutants and truncations of RNF146 were generated using site-directed mutagenesis (Stratagene) and confirmed by sequencing. BRCA1-BARD1 (residues 1-112 and 1-115 respectively), UbcH5a, UbcH5b, UbcH5c, Ub, UbcH5c(Ser22Arg/ Cys85Ser), and wheat E1 were purified as previously described 25, 29 . The oxyesterlinked E2-O-Ub conjugate (UbcH5c(Ser22Arg/Cys85Ser)-O-Ub) was generated and purified as previously described 30 .
All Escherichia coli (BL21) cultures were grown to an attenuance (D) at 600 nm of 0.6-1.2 in LB media or minimal MOPS media supplemented with 15 N-ammonium chloride (Cambridge Isotope Labs) for NMR spectroscopy. Protein expression was induced in the presence of 200 mM isopropylthiogalactoside (IPTG) at 16 uC or 24 uC for 16-18 h. Bacterially expressed GST-RNF146(RING-WWE) or GST-RNF146(RING) (residues 30-89) was bound to glutathione sepharose 4B resin (GE Healthcare), washed, and eluted with 10 mM glutathione in a buffer containing 25 mM sodium phosphate, pH 7.6, and 200 mM NaCl. GST was then cleaved from proteins using a His 6 -TEV protease for 1 h at 37 uC (or overnight at 4 uC) and the samples were dialysed overnight at 4 uC into 4 l of phosphate buffer (25 mM sodium phosphate, pH 7.6, 200 mM NaCl). Dialysed proteins were then run through Ni 21 NTA resin (GE Healthcare) to capture TEV and subsequently glutathione sepharose 4B resin to capture GST. After concentrating in the presence of 2 mM dithiothreitol (DTT), RNF146(RING-WWE) was purified using Superdex 75 (GE Healthcare) equilibrated with 25 mM phosphate, pH 7.0, 150 mM NaCl. Similarly, TNKS(5ARC) was purified using glutathione sepharose 4B resin, followed by on-column TEV cleavage overnight at 4 uC. The untagged TNKS(5ARC) was subsequently purified by anion exchange column using a Q column (GE Healthcare). Full-length mouse TNKS1 was partially purified by Ni 21 NTA resin (GE Healthcare). Full-length His 6 -T7-RNF146 was purified using a Ni 21 NTA resin (GE Healthcare), followed by ion exchange on a HiTrap Q column (GE Healthcare) and SEC using a Superdex 200 10/300 column (GE Healthcare). Protein concentrations were determined by their ultraviolet absorbance at 280 nm, and confirmed with Coomassie-stained SDS-PAGE. Lysine reactivity assay. For Coomassie or Oriole (BioRad)-stained gels, UbcH5,Ub conjugates were generated in a solution containing 100 mM E2, 1.5 mM wheat E1, 200 mM Ub (Lys-deficient (K0) mutant: Lys6Arg, Lys11Arg, Lys29Arg, Lys33Arg, Lys48Arg, Lys63Arg and Lys27Met), 2.5 mM MgCl 2 and 2 mM ATP (Sigma-Aldrich) in PBS at 37 uC for 30 min. The conjugate was purified by SEC before E2,Ub/lysine reactions. E2,Ub conjugates were added to E3 samples (wild-type or mutant full-length RNF146, RNF146(RING-WWE) or RNF146(RING)) for a final concentration of 25 mM E2 and 4 or 8 mM E3 (all reactions in Fig. 3c were performed at 8 mM E3), and 25 mM iso-ADPr where indicated. Time zero samples were taken just before the addition of buffered L-lysine HCl (Sigma-Aldrich) to a final concentration of 40 mM and incubated at 35 uC. Time points were collected between 1 and 15 min; the reactions were quenched in 23 non-reducing SDS loading buffer, and analysed by SDS-PAGE.
For western blot analysis, 5 mM UbcH5a enzyme was charged with 0.5 mM E1, 5 mM Ub (HA-tagged, K0 mutant: Lys6Arg, Lys11Arg, Lys29Arg, Lys33Arg, Lys48Arg, Lys63Arg and Lys27Met), 10 mM MgCl 2 , and 5 mM ATP for 30-40 min at 37 uC. Reaction mixtures were added to tubes containing E3 for a final concentration of 5 mM E3 and 10 mM iso-ADPr when appropriate. Time zero samples were taken just before addition of buffered L-lysine HCl (Sigma-Aldrich) to a final concentration of 25 mM and incubated at 35 uC. Reactions were quenched in 23 non-reducing SDS loading buffer, analysed by western blots with mouse anti-HA (monoclonal antibody, Covance MMS-101P). Auto-ubiquitination. In vitro auto-ubiquitination was performed in a reaction mixture containing 1 mM E1, 3 mM UbcH5c, 45 mM ubiquitin, 5 mM MgCl 2 , and 3 mM His 6 -T7-RNF146. PAR or iso-ADPr was added to a final concentration of about 20 mM (ADPr units) or 10 mM respectively. ATP was added to a final concentration of 5 mM after collecting time zero samples. The samples were then incubated at 37 uC and time points were collected between 0 and 12 min. Reactions were quenched with 103 reducing SDS loading buffer, boiled and analysed by western blot using mouse anti-T7 antibody (monoclonal antibody, Novagen 69522). Limited proteolysis. Limited proteolysis was performed by incubating 10 mg RNF146(RING-WWE) (residues 30-183) or RNF146(Linker-WWE) (residues 83-183) with 50 ng subtilisin (Sigma-Aldrich) in the presence or absence of 150 mM iso-ADPr for 1 h at room temperature. The reaction was quenched with 53 SDS loading buffer and the resulting digests were resolved by SDS-PAGE and stained with Coomassie. SEC-MALS. SEC-MALS experiments were performed at room temperature with a Superdex 200 10/300 column (GE Healthcare) and a miniDAWN TREOS MALS detector (Wyatt Technology). About 200 mg of full-length RNF146, TNKS(5ARC), and TNKS(5ARC)-RNF146 complex was injected in each run. The column was run with buffer containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 2 mM DTT. The light scattered by a protein is directly proportional to its weight-average molecular mass and concentration. Crystallization of the RNF146(RING-WWE)-UbcH5a-iso-ADPr complex. RNF146(RING-WWE) was bound to an SP anion exchange column (GE Healthcare) and then eluted with buffer containing 20 mM Tris-HCl, pH 7.0, 5% (v/v) glycerol, 2 mM DTT, and 500 mM NaCl. The protein was eluted with a salt concentration of ,150 mM NaCl and was subsequently concentrated to 2.4 mg ml 21 for crystallization. RNF146(RING-WWE) was mixed with iso-ADPr ligand in a microcentrifuge tube for a final concentration of 133 mM protein to 267 mM ligand and incubated on ice for 30 min. Eighty microlitres of this solution was mixed with 20 ml of His 6 -UbcH5a in a 25 mM sodium phosphate, pH 7.0, 150 mM NaCl buffer, for final concentrations of 120 mM E2 and 106 mM E3. This mixture was incubated on ice for 30 min. Crystals were obtained using the hanging drop method by adding 1 ml of the above protein-ligand mixture to 1 ml of a well solution containing 800 mM sodium citrate, 80 mM Tris-HCl, pH 7.0, 160 mM NaCl, 4 mM DTT, and 20 mM trimethylamine HCl. Crystals formed in 24-36 h at room temperature. Crystals were frozen with liquid nitrogen in a cryoprotectant composed of 800 mM sodium citrate, 96 mM Tris-HCl, pH 7.0, 280 mM NaCl, 5 mM DTT, and 20% (v/v) glycerol. X-ray data collection and structure determination. Crystal screening and data collection were performed at the ALS, beamline 8.2.1. All diffraction data were processed by the HKL2000 package 31 in the space group P2 1 2 1 2. The structure was determined, at 1.9 Å resolution, by single-wavelength anomalous dispersion (SAD) using one data set collected at a wavelength of 1.28295 Å , which was also used for refinement (Extended Data Table 1 ). The zinc sites and the initial phases were determined by PHENIX 32 . Four zinc sites were found in one asymmetric unit, and the experimental electron density map clearly showed the presence of two RNF146 (RING-WWE)-UbcH5a complexes with two ligands in one asymmetric unit. The complex model was improved using iterative cycles of manual rebuilding with the program COOT 33 and refinement with Refmac5 of the CCP4 6.4.0 program suite 34 . There are no Ramachandran outliers (96.0% most favoured, 4.0% allowed). The electrostatic potential surfaces shown were generated with the APBS tool in Pymol 35 . ITC. ITC was performed on a VP-ITC Microcal colorimeter (Microcal) at 25 uC for RNF146(RING-WWE) and the RNF146(RING-WWE) mutants. Protein and iso-ADPr were buffer exchanged into 20 mM HEPES, pH 7.5, 150 mM NaCl, and 1 mM DTT using SEC on a Superdex 75 10/300 column (GE Healthcare), eluting at a final concentration of ,15-20 mM. The ligand, iso-ADPr, was diluted in the same buffer to ,500 mM. Both ligand and protein were degassed before use. Ligand was injected in 5 ml quantities every 5 min for a total of 25-40 injections into a 1.4218-ml protein chamber. Data were analysed using Origin 7.0, fitting curves to a one-site model. NMR spectroscopy. Two-dimensional 1 H-15 N HSQC-TROSY experiments where performed on a Bruker 500 MHz AVANCE II NMR spectrometer. All data were obtained with 200 mM 15 N-labelled protein. Data were processed with NMRPipe 36 , and peak intensities (I) and chemical shift perturbations (CSPs) were measured in NMRViewJ 37 (One Moon Scientific). Peak intensity changes of 15 N-labelled E2 (UbcH5c(Ser22Arg/Cys85Ser)) were measured relative to free E2 (I E3 bound /I free ), and peaks affected by binding were identified by one standard deviation away from the mean I E3-bound /I free value. Chemical shift perturbations were determined by the equation Dd j 5 [(Dd j 15 N/5) 2 1 (Dd j 1 H) 2 ] 1/2 ; peaks with CSPs greater than one standard deviation from the mean were considered significantly perturbed. Both peak broadening and CSPs were mapped onto the E2 surface (PDB code 2FUH) 29 to show residues affected by E3 binding. For 1 H-15 N HSQC-TROSY experiments of the oxyester-linked E2-O-Ub conjugate (UbcH5c(Ser22Arg/Cys85Ser)-O-Ub), Ub and UbcH5c peak intensities and CSPs were analysed separately as indicated above. For NMR experiments of the E2-O-Ub conjugate, peak broadening and CSPs were mapped onto the UbcH5b and Ub surfaces of the BIRC7-UbcH5b-O-Ub structure 24 (PDB accession 4AUQ) to show residues most affected when E3 binds. GST pull-down assays. Approximately 3 mM of purified GST or GST-RNF146 (wild type, truncations or mutants) and about 6.7 mM of untagged TNKS(5ARC) were incubated with 25 ml of GSH sepharose 4B resin (GE Healthcare) for 1 h at room temperature in binding buffer (40 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.04% (v/v) Tween 20, and 2 mM DTT; total volume of 200 ml). The beads were then washed with 200 ml buffer three times. Proteins were resolved on SDS-PAGE and stained with Coomassie.
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